Home > Income Statement > DIVIS LABORATORIES

DIVIS LABORATORIES
Revenue

    Back to Income Statement
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
AD     Remove this Ad

DIVIS LABORATORIES Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹9,360 Cr₹7,845 Cr₹7,767 Cr₹8,960 Cr₹6,969 Cr

What is the latest Revenue of DIVIS LABORATORIES ?

The latest Revenue ratio of DIVIS LABORATORIES is ₹9,360 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹9,360 Cr
Mar2024₹7,845 Cr
Mar2023₹7,767 Cr
Mar2022₹8,960 Cr
Mar2021₹6,969 Cr

How is Revenue of DIVIS LABORATORIES Trending?

Years Revenue % Change
Mar2025 ₹9,360 Cr
19.31
Mar2024 ₹7,845 Cr
1.00
Mar2023 ₹7,767 Cr
-13.31
Mar2022 ₹8,960 Cr
28.56
Mar2021 ₹6,969 Cr -

Compare Revenue of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹161,288.6 Cr -4.7% -1.8% 10.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,693.0 Cr -1.7% 4% 11.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,281.0 Cr -3.7% 4.5% 42.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,422.0 Cr -3% 0% 15.4% Stock Analytics
CIPLA ₹104,915.0 Cr -2.6% -2.3% -10.1% Stock Analytics
MANKIND PHARMA ₹86,354.7 Cr -6.5% 0.6% -5.4% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

-4.7%

-1.8%

10.1%

SENSEX

-2.7%

-10.4%

1.6%


You may also like the below Video Courses